Published in Blood on August 01, 1984
Calcium in red blood cells-a perilous balance. Int J Mol Sci (2013) 1.02
Modulation of erythrocyte membrane material properties by Ca2+ and calmodulin. Implications for their role in regulation of skeletal protein interactions. J Clin Invest (1988) 0.96
Morphologically homogeneous red blood cells present a heterogeneous response to hormonal stimulation. PLoS One (2013) 0.84
Isolation and partial characterization of antibody- and globin-enriched complexes from membranes of dense human erythrocytes. Biochem J (1991) 0.84
A mechanism of ineffective erythropoiesis in β-thalassemia/Hb E disease. Haematologica (2009) 0.82
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed (2000) 2.24
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol (1978) 2.07
Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature (1990) 1.99
The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci (1974) 1.99
Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley's anemia) Blood (1993) 1.93
Proliferation and maturation of human erythroid progenitors in liquid culture. Blood (1989) 1.78
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang (2010) 1.60
The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem (1971) 1.57
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. QJM (2008) 1.56
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med (1993) 1.51
Organization of enzymes in human erythrocyte membranes. Am J Physiol (1966) 1.51
Granulopoiesis in acute myeloid leukemia and preleukemia. N Engl J Med (1971) 1.50
The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major. Blood (2000) 1.49
Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer (1984) 1.49
The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus (2003) 1.48
Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril (1998) 1.46
A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia. Blood (2000) 1.44
High prevalence of low serum vitamin B12 in a multi-ethnic Israeli population. Br J Haematol (2001) 1.43
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
Activated oxygen and haemolysis. Br J Haematol (1975) 1.41
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. J Biol Chem (1971) 1.38
Membrane phospholipid asymmetry in human thalassemia. Blood (1998) 1.36
Granulopoiesis in neutropenic disorders. Blood (1973) 1.29
Cardiopulmonary assessment in beta-thalassemia major. Chest (1990) 1.26
Oxidative denaturation of red blood cells in thalassemia. Semin Hematol (1990) 1.24
Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci (2005) 1.22
Lipid membrane peroxidation in beta-thalassemia major. Blood (1976) 1.18
Denaturation of the normal and abnormal hemoglobin molecule. Semin Hematol (1974) 1.17
Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease. Nature (1969) 1.12
Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia. Blood (1992) 1.11
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
Drug-induced erythrocyte membrane internalization. J Clin Invest (1972) 1.08
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood (1996) 1.08
Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study. Circulation (1983) 1.06
beta 0-Thalassemia complicated by autoimmune hemolytic anemia. Globin synthesis during immunosuppressive therapy. Acta Haematol (1980) 1.06
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol (1986) 1.05
Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci (1970) 1.05
Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr J Med Sci (1972) 1.05
Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis (2005) 1.04
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) (1978) 1.04
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02
A new polymorphism in the human beta-globin gene useful in antenatal diagnosis. J Clin Invest (1981) 1.02
Oxidative red blood cell membrane injury in the pathophysiology of severe mouse beta-thalassemia. Blood (1992) 1.00
Spontaneous anticoagulant-induced hemopericardium with tamponade. Acta Haematol (1982) 1.00
Erythropoietin triggers a burst of GATA-1 in normal human erythroid cells differentiating in tissue culture. Nucleic Acids Res (1993) 1.00
Absence of beta mRNA in beta0-thalassemia in Kurdish Jews. Blood (1978) 1.00
Novel treatment options in the severe beta-globin disorders. Br J Haematol (1995) 0.99
Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood (1987) 0.99
The demonstration of ferrihemochrome intermediates in heinz body formation following the reduction of oxyhemoglobin A by acetylphenylhydrazone. Biochim Biophys Acta (1975) 0.99
Treatment of human ulcers by application of macrophages prepared from a blood unit. Exp Gerontol (1998) 0.98
Blood group phenotypes and hemoglobin S. An anthropologic study in two Israeli Arab communities. Acta Haematol (1976) 0.98
Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with beta-thalassemia (major and intermedia). J Lab Clin Med (1976) 0.98
Mean corpuscular volume of heterozygotes for beta-thalassemia correlates with the severity of mutations. Blood (1992) 0.98
The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells (1993) 0.97
Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood (1993) 0.97
Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. Proc Natl Acad Sci U S A (1979) 0.96
Juvenile leg ulceration in beta-thalassemia major and intermedia. Plast Reconstr Surg (1982) 0.96
The analogous mechanisms of enzymatic inactivation induced by ascorbate and superoxide in the presence of copper. J Biol Chem (1983) 0.96
Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol (1993) 0.96
Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings. Transfus Med (2007) 0.95
Blood group phenotypes and the origin of sickle cell hemoglobin in Sicilians. Acta Haematol (1978) 0.94
Visceral leishmaniasis: a difficult diagnosis and unusual causative agent. J Infect Dis (1991) 0.94
Multiple brain abscesses caused by Streptococcus bovis. J Infect (1991) 0.93
Erythremia after renal transplantation. N Engl J Med (1965) 0.93
ATP synthesis in human erythrocyte membranes. Biochim Biophys Acta (1967) 0.93
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol (1999) 0.93
The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Radic Biol Med (1998) 0.93
Two mutations in the beta-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. Proc Natl Acad Sci U S A (1992) 0.92
Actin-activated ATPase in human red cell membranes. Blood (1981) 0.92
Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation. Am J Hematol (1997) 0.91
Inhibition of erythrocyte Ca2+-ATPase by activated oxygen through thiol- and lipid-dependent mechanisms. Biochim Biophys Acta (1986) 0.91
Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. J Clin Invest (1989) 0.91
The instability of the membrane skeleton in thalassemic red blood cells. Blood (1995) 0.91
Nonspecific serum iron in thalassemia: quantitation and chemical reactivity. Am J Hematol (1979) 0.91
Expression of granulocytic functions by leukemic promyelocytic HL-60 cells: differential induction by dimethylsulfoxide and retinoic acid. Cell Differ (1987) 0.90
Variability in ouabain-induced inhibition of human erythrocyte membrane (Na+ K+)-ATPase. Biochim Biophys Acta (1969) 0.90
In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood (1991) 0.90
Homozygous beta0- and beta+ - thalassemia in Kurdish Jews and Arabs. Hemoglobin (1977) 0.90
Pancytopenia with hypercellular bone marrow--a possible paraneoplastic syndrome in carcinoma of the lung: a report of three cases. Am J Hematol (1984) 0.90
Familial thrombocytopenic thrombocytopathy. Br J Haematol (1967) 0.90
Why would young people donate blood? A survey-based questionnaire study. Vox Sang (2009) 0.90
Ultrastructural studies in -thalassaemia major. Br J Haematol (1973) 0.89
The interaction of hemoglobin O Arab with Hb S and beta+ thalassemia among Israeli Arabs. Hum Genet (1985) 0.89
Formation of hemichromes from oxidized hemoglobin subunits. Ann N Y Acad Sci (1969) 0.89
Alteration of membrane phospholipid bilayer organization in human erythrocytes during drug-induced endocytosis. J Clin Invest (1983) 0.88
Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke. J Cereb Blood Flow Metab (1997) 0.88
Mechanism of desferrioxamine-induced iron excretion in thalassaemia. Br J Haematol (1979) 0.88
Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60). J Cell Physiol (1982) 0.88
Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) (1993) 0.88
Membrane deformability and the capacity for shape change in the erythrocyte. Blood (1989) 0.88